Merck & Company (MRK)

May 31, 2025, 8:13 AM EDT - 1 day ago

Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial

GILD

May 31, 2025, 8:00 AM EDT - 1 day ago

KEYTRUDA® (pembrolizumab) Plus Trodelvy® (sacituzumab govitecan-hziy) Reduced Risk of Disease Progression or Death by 35% Versus KEYTRUDA Plus Chemotherapy in First-Line PD-L1+ Metastatic Triple-Negative Breast Cancer (TNBC)

May 30, 2025, 12:23 PM EDT - 1 day ago

Carat Group's Fred Hassan dives into what pharma companies to watch at 2025 ASCO Annual Meeting

AMGN GSK PFE

May 30, 2025, 8:05 AM EDT - 2 days ago

Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations

May 30, 2025, 8:00 AM EDT - 2 days ago

Merck's Investigational Zilovertamab Vedotin at 1.75 mg/kg Dose Plus Standard of Care Showed Promising Antitumor Activity, Including Complete Response Rate, in Patients With Relapsed/Refractory DLBCL in Phase 2 Portion of waveLINE-003 Trial

May 29, 2025, 7:42 PM EDT - 2 days ago

Merck & Co., Inc. (MRK) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

May 29, 2025, 7:14 AM EDT - 3 days ago

Merck, Daiichi withdraw US application for 'guided missile' cancer drug

May 29, 2025, 7:00 AM EDT - 3 days ago

Patritumab Deruxtecan Biologics License Application for Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer Voluntarily Withdrawn

May 27, 2025, 3:46 PM EDT - 4 days ago

Merck Proves Why It's Still A Top Pharma Pick

May 27, 2025, 1:24 PM EDT - 4 days ago

Merck Announces Third-Quarter 2025 Dividend

May 26, 2025, 12:00 PM EDT - 5 days ago

Should You Buy MRK Stock At $80?

May 23, 2025, 11:05 AM EDT - 8 days ago

Merck: Defensive Yield Meets Long-Term Optionality

May 22, 2025, 5:43 PM EDT - 9 days ago

Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025

May 22, 2025, 12:30 PM EDT - 9 days ago

Merck: Undervalued In Light Of Key Risks

May 22, 2025, 8:15 AM EDT - 10 days ago

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

PFE XRAY

May 22, 2025, 6:45 AM EDT - 10 days ago

Merck to Participate in the Bernstein 41st Annual Strategic Decisions Conference

May 21, 2025, 8:15 AM EDT - 11 days ago

Merck Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active Lupus Rash

May 19, 2025, 11:36 AM EDT - 12 days ago

I'm Putting Cash To Work: 2 Rock-Solid Dividends At Bargain Prices

FRT

May 16, 2025, 6:45 AM EDT - 16 days ago

Merck to Present New Clinical and Outcomes Research Data at The American Thoracic Society's (ATS) 2025 International Conference Demonstrating Commitment to Advancing Research in Pulmonary Arterial Hypertension

May 15, 2025, 6:45 AM EDT - 17 days ago

Merck Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Platinum-Resistant Recurrent Ovarian Cancer Whose Tumors Expressed PD-L1 and in All Comers

May 14, 2025, 5:15 PM EDT - 17 days ago

FDA Approves Merck's WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)

May 14, 2025, 4:50 PM EDT - 17 days ago

Merck & Co., Inc. (MRK) BofA Securities 2025 Healthcare Conference (Transcript)

May 14, 2025, 12:48 PM EDT - 17 days ago

US FDA expands use of Merck's cancer drug for adrenal gland tumors

May 14, 2025, 9:55 AM EDT - 17 days ago

Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.

ABBV REGN

May 14, 2025, 8:46 AM EDT - 17 days ago

Germany's Merck drops China surcharge on orders after US-China tariff deal

May 13, 2025, 6:45 AM EDT - 19 days ago

Research on Novel Treatment Approaches and Scientific Advances From Merck's Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025

May 12, 2025, 3:54 PM EDT - 19 days ago

Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know

ABBV GSK JNJ LLY NVO NVS PFE

May 12, 2025, 3:52 PM EDT - 19 days ago

President Trump's EO to lower drug prices is the beginning of a long process, says Jeff Jonas

ABBV CI CVS LLY PFE REGN UNH

May 12, 2025, 1:14 PM EDT - 19 days ago

Drugmakers are spared worst-case drug pricing scenario for now

ABBV JNJ LLY PFE

May 12, 2025, 12:36 PM EDT - 19 days ago

Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices

ABBV AMGN AZN GILD GSK JNJ LLY

May 12, 2025, 12:30 PM EDT - 19 days ago

Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet

ABBV AMGN BIIB BMY GILD JNJ LLY

May 12, 2025, 11:24 AM EDT - 19 days ago

Trump says executive order will slash the cost of prescription drugs

ABBV JNJ LLY PFE

May 12, 2025, 10:47 AM EDT - 19 days ago

Trump Announces Executive Order to Lower Drug Prices

JNJ LLY PFE

May 12, 2025, 9:24 AM EDT - 19 days ago

White House release details on executive order on drug prices: Here's what to know

JNJ LLY PFE

May 12, 2025, 5:30 AM EDT - 20 days ago

Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices

ABBV AMGN AZN GSK JNJ LLY NVO

May 12, 2025, 2:37 AM EDT - 20 days ago

European pharma stocks follow Asia peers down as Trump moves to cut prices

ABBV AMGN LLY PFE

May 12, 2025, 1:00 AM EDT - 20 days ago

Jeito Capital Strengthens Leadership for Next Chapter of Growth: Mehdi Ainouche Promoted to Partner, Julien Elric to Senior Principal

BIIB

May 8, 2025, 7:23 PM EDT - 23 days ago

Pressure is still on the pharma sector, says Mizuho's Jared Holz

ABBV AMGN BMY GILD JNJ LLY NVO

May 8, 2025, 7:22 AM EDT - 24 days ago

Merck Animal Health announces $895 million investment in Kansas

May 8, 2025, 6:45 AM EDT - 24 days ago

Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto

May 7, 2025, 6:45 AM EDT - 25 days ago

Merck to Participate in the Bank of America 2025 Global Healthcare Conference

May 6, 2025, 2:30 PM EDT - 25 days ago

Pharma imports to US surged in March as drugmakers look to avoid tariffs

PFE

May 3, 2025, 2:00 PM EDT - 4 weeks ago

Pharmaceutical giant details plan to create thousands of US jobs

May 3, 2025, 9:46 AM EDT - 4 weeks ago

Dogs Of The Dow Chase May's 'Safer' Buy

AMGN AMZN BA CRM CSCO CVX DIS

May 3, 2025, 8:30 AM EDT - 4 weeks ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (May 2025)

ACN ADP AES AMH ARCC ARE BTI

May 1, 2025, 10:23 PM EDT - 4 weeks ago

Top 10 High-Yield Dividend Stocks To Consider In May 2025

AMT CMCSA MTB NEE PEP PNC QSR

Apr 30, 2025, 4:12 PM EDT - 4 weeks ago

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom

ABBV ABT DXCM GSK JNJ LLY NVS

Apr 30, 2025, 5:17 AM EDT - 4 weeks ago

3 Names I Picked Up In The Latest Market Slump

BLK PPG

Apr 29, 2025, 2:24 PM EDT - 4 weeks ago

Merck to invest $1B in new US plant to make blockbuster cancer treatment Keytruda

Apr 29, 2025, 6:45 AM EDT - 4 weeks ago

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware